Contact Us
Schwab Client Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IVBXF

Recent news which mentions IVBXF

Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
Tickers IVBXF SNY
Tags Briefs News Market News
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Tickers ABBV AMRX BNTX BYSI
Tags VALN BYSI MRSN
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags Top Stories IOVA Market News
From Benzinga
FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting
Tickers IVBIY IVBXF LLY
Tags IVBIY News Market News
From Benzinga
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
Tickers IVBIY IVBXF LLY
Tags General Benzinga Biotech
From Benzinga
Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate
Tickers IVBIY IVBXF
Tags IVBIY Health Care News
From Benzinga
Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates
Tickers BOLT IVBIY IVBXF
Tags IVBXF Contracts News
From Benzinga
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Tickers IVBIY IVBXF LLY
Tags News Market News IVBIY
From Benzinga
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Tickers IVBIY IVBXF LLY
Tags Non/Small Cell Lung Cancer LLY IVBXF
From Benzinga
Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer
Tickers INCY IVBIY IVBXF
Tags Benzinga Biotech General
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.